Reece Fulgham
Senior Operational and Restructuring Executive
Reece Fulgham
Senior Operational and Restructuring Executive
Meet Reece Fulgham
Senior financial executive, former CPA and turnaround specialist with 40+ years of accounting, finance, operations, and turnaround experience across 50+ companies in diverse industries. Proven track record of success and value creation as Board Chairman, Assistant to Chairman, Independent Board Director, CEO, CRO, CFO, and Vice President of Finance. Specializes in stabilizing distressed companies with limited liquidity horizons, requiring urgent operational and financial restructuring to achieve outcomes ranging from robust operational and financial results to liquidation. Extensive domestic and international experience positioning and selling companies and/or non-core assets. Expertise in managing complex organizations through challenging times, leading by example, and cultivating "Lead From the Front" management teams.
Extensive Board of Directors Experience: Mr. Fulgham has served as an Independent Director on twelve middle-market company Boards of Directors, acting as Chairman for one and Audit Committee Chairman for ten mostly private equity portfolio companies. Also participated in multiple committees including compensation, legal, compliance, investment and restructuring special committees.
Deep Cannabis professional network from seed to sale.
Executive Experience
Advisory
Reece Fulgham has held key advisory roles across diverse industries, specializing in financial restructuring and turnaround management. As CRO and CFO, he led complex restructurings at companies like Aviron Pictures, Broadstripe, and Kinetics Group. His impact extended to high-profile brands like Hollywood Video and MedMen, where he implemented measures that restored financial stability.
Board Work
Reece has served on over a dozen Boards, often as Independent Director or Audit Committee Chairman, with a focus on private equity and turnaround scenarios. Highlights include leading a $434 million sale as Chairman of LMG2 and driving EBITDA growth at Cornerstone Healthcare. His board work has consistently delivered strong returns, including a 30x equity gain at Trussway Manufacturing.